TABLE 7.

Running clinical trial studies for validation of IL-6 Inhibitory drugs (https://clinicaltrials.gov/ct2/results).

Sl. No.	Title	NCT No.	Therapeutic Dose	Phase	Location
1	Evaluating the efficacy of TCZ	NCT04356937	8 mg	3	U.S.
2	Evaluating the efficacy of TCZ and corticosteroids to curtail CoVs infection	NCT04345445	8 mg	3	Malaysia
3	Determination of the efficacy of TCZ Naproxen therapy	NCT04325633	250 mg (BID)	3	Not specified
4	Validating TCZ Baricitinib therapy in SARS-CoV-2 infected patients	NCT04358614	4 mg	2,3	Italy
5	Evaluating safety and efficacy of Baricitinib therapy	NCT04340232	2 mg	2,3	U.S.